| NF-κB restricts inflammasome activation via elimination of damaged mitochondria Z Zhong, A Umemura, E Sanchez-Lopez, S Liang, S Shalapour, J Wong, ... Cell 164 (5), 896-910, 2016 | 980 | 2016 |
| New mitochondrial DNA synthesis enables NLRP3 inflammasome activation Z Zhong, S Liang, E Sanchez-Lopez, F He, S Shalapour, X Lin, J Wong, ... Nature 560 (7717), 198-203, 2018 | 825 | 2018 |
| Immunity, inflammation, and cancer: an eternal fight between good and evil S Shalapour, M Karin The Journal of clinical investigation 125 (9), 3347-3355, 2015 | 764 | 2015 |
| Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy S Shalapour, J Font-Burgada, G Di Caro, Z Zhong, E Sanchez-Lopez, ... Nature 521 (7550), 94-98, 2015 | 521 | 2015 |
| Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling G He, D Dhar, H Nakagawa, J Font-Burgada, H Ogata, Y Jiang, ... Cell 155 (2), 384-396, 2013 | 480 | 2013 |
| Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity S Shalapour, XJ Lin, IN Bastian, J Brain, AD Burt, AA Aksenov, ... Nature 551 (7680), 340-345, 2017 | 478 | 2017 |
| Hybrid periportal hepatocytes regenerate the injured liver without giving rise to cancer J Font-Burgada, S Shalapour, S Ramaswamy, B Hsueh, D Rossell, ... Cell 162 (4), 766-779, 2015 | 463 | 2015 |
| Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis K Wang, MK Kim, G Di Caro, J Wong, S Shalapour, J Wan, W Zhang, ... Immunity 41 (6), 1052-1063, 2014 | 324 | 2014 |
| Mutations and Deletions of the TP53 Gene Predict Nonresponse to Treatment and Poor Outcome in First Relapse of Childhood Acute Lymphoblastic Leukemia J Hof, S Krentz, C Van Schewick, G Körner, S Shalapour, P Rhein, ... Journal of clinical oncology 29 (23), 3185-3193, 2011 | 243 | 2011 |
| Genetic and biological hallmarks of colorectal cancer J Li, X Ma, D Chakravarti, S Shalapour, RA DePinho Genes & development 35 (11-12), 787-820, 2021 | 228 | 2021 |
| Fructose stimulated de novo lipogenesis is promoted by inflammation J Todoric, G Di Caro, S Reibe, DC Henstridge, CR Green, A Vrbanac, ... Nature metabolism 2 (10), 1034-1045, 2020 | 218 | 2020 |
| Immunotherapy, inflammation and colorectal cancer CR Lichtenstern, RK Ngu, S Shalapour, M Karin Cells 9 (3), 618, 2020 | 214 | 2020 |
| Preclinical models for studying NASH-driven HCC: how useful are they? MA Febbraio, S Reibe, S Shalapour, GJ Ooi, MJ Watt, M Karin Cell metabolism 29 (1), 18-26, 2019 | 210 | 2019 |
| Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts M Ammirante, S Shalapour, Y Kang, CAM Jamieson, M Karin Proceedings of the National Academy of Sciences 111 (41), 14776-14781, 2014 | 190 | 2014 |
| Mass spectrometry searches using MASST M Wang, AK Jarmusch, F Vargas, AA Aksenov, JM Gauglitz, K Weldon, ... Nature biotechnology 38 (1), 23-26, 2020 | 182 | 2020 |
| Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition A Umemura, EJ Park, K Taniguchi, JH Lee, S Shalapour, MA Valasek, ... Cell metabolism 20 (1), 133-144, 2014 | 182 | 2014 |
| Liver cancer initiation requires p53 inhibition by CD44-enhanced growth factor signaling D Dhar, L Antonucci, H Nakagawa, JY Kim, E Glitzner, S Caruso, ... Cancer cell 33 (6), 1061-1077. e6, 2018 | 181 | 2018 |
| Pas de deux: control of anti-tumor immunity by cancer-associated inflammation S Shalapour, M Karin Immunity 51 (1), 15-26, 2019 | 174 | 2019 |
| Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling E Sanchez-Lopez, E Flashner-Abramson, S Shalapour, Z Zhong, ... Oncogene 35 (20), 2634-2644, 2016 | 154 | 2016 |
| Commensal microflora and interferon‐γ promote steady‐state interleukin‐7 production in vivo S Shalapour, K Deiser, Ö Sercan, J Tuckermann, K Minnich, G Willimsky, ... European journal of immunology 40 (9), 2391-2400, 2010 | 104 | 2010 |
